Memory B cell dysregulation in HIV-1-infected individuals

被引:10
|
作者
Carrillo, Jorge [1 ]
Negredo, Eugenia [2 ]
Puig, Jordi [2 ]
Manuel Molinos-Albert, Luis [1 ]
Luisa Rodriguez de la Concepcion, Maria [1 ]
Curriu, Marta [1 ]
Massanella, Marta [1 ]
Navarro, Jordi [3 ]
Crespo, Manel [4 ]
Vinets, Ester [5 ]
Milla, Fuensanta [5 ,6 ]
Clotet, Bonaventura [1 ,2 ,7 ,8 ]
Blanco, Julia [1 ,8 ,9 ]
机构
[1] Hosp Germans Trias i Pujol, HIVACAT, IrsiCaixa AIDS Res Inst, Badalona, Spain
[2] Hosp Germans Trias i Pujol, Fundacio Lluita Sida, Badalona, Spain
[3] Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain
[4] Complexo Hosp Univ Vigo, IIS Galicia Sur, Internal Med Dept, Infect Dis Unit, Vigo, Spain
[5] Hosp Germans Trias i Pujol, ICO, Hematol Dept, Badalona, Spain
[6] Josep Carreras Leukaemia Res Inst, Badalona, Spain
[7] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain
[8] Univ Vic Univ Cent Catalunya UVic UCC, Vic, Spain
[9] Germans Trias i Pujol Res Inst IGTP, Barcelona, Catalonia, Spain
关键词
apoptosis; antiretroviral treatment; HIV-1; immune system; memory B cells; splenic function; HIV-1; INFECTION; SEROLOGICAL MEMORY; RESPONSES; DISEASE; EXPRESSION; POPULATION; SUBPOPULATIONS; MAINTENANCE; COMPARTMENT; ACTIVATION;
D O I
10.1097/QAD.0000000000001686
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective:To characterize the effect of the HIV-1 infection and antiretroviral treatment (ART) in the human memory B (MEB)-cell compartment.Design:A cross-sectional study was designed to analyze MEB cells of HIV-1(+) ART treated and ART-naive study participants, and uninfected individuals.Methods:Frequency and absolute counts of MEB cell subsets in blood were determined by multicolor flow cytometry. Spontaneous cell death and B-cell proliferative capacity was evaluated in vitro by cell culture and flow cytometry. Splenic function was determined by pitted erythrocytes quantification in HIV-1(+) ART-treated study participants.Results:HIV-1(+) ART-treated individuals did not show functional hyposplenism despite the lack of recovery IgM(+)IgD(+)CD27(+) marginal zone-like B cells. Moreover, two germinal center-dependent MEB cells subsets were also dysregulated in HIV-1(+) individuals: IgM(+)IgD(-)CD27(+) (IgM only) cells were increased, whereas the switched subset (IgM(-)IgD(-)) was reduced in viremic individuals. Althought ART restored the numbers of these populations; the switched MEB cells were enriched in CD27(-) cells, which showed the highest susceptibility to spontaneous cell death ex vivo. In addition, B cells from viremic individuals showed a poor response to B-cell receptor and toll-like receptor 9 stimulation that was circumvented when both stimuli were used simultaneously.Conclusion:B cells from HIV-1(+) study participants show a poor stimulation capacity, that may be bypassed by the proper combination of stimuli, and a dysregulated MEB cell pool that suggest an affectation of the germinal center reaction, only partially normalized by ART. Interestingly, hyposplenism does not explain the lack of recovery of the marginal zone-like B cells in ART-treated HIV-1(+) individuals.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 50 条
  • [31] Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals
    Barcelo, Catalina
    Gaspar, Frederic
    Aouri, Manel
    Panchaud, Alice
    Rotger, Margalida
    Guidi, Monia
    Cavassini, Matthias
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 1933 - 1942
  • [32] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    CLINICAL PHARMACOKINETICS, 2005, 44 (08) : 849 - 861
  • [33] Merkel cell carcinoma in an HIV-1-infected man
    Cone, LA
    Gade-Andavolu, R
    Lesnick, RH
    Aitken, D
    Bush, WS
    Potts, BE
    AIDS, 2006, 20 (03) : 474 - 475
  • [34] Drug interaction of fluvoxamine and fluoxetine with nevirapine in HIV-1-infected individuals
    de Maat, MM
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Mairuhu, ATA
    Beijnen, JH
    CLINICAL DRUG INVESTIGATION, 2003, 23 (10) : 629 - 637
  • [35] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    Bregt S. Kappelhoff
    Alwin D. R. Huitema
    Zeynep Yalvaç
    Jan M. Prins
    Jan W. Mulder
    Pieter L. Meenhorst
    Jos H. Beijnen
    Clinical Pharmacokinetics, 2005, 44 : 849 - 861
  • [36] Cytokine Expression During Syphilis Infection in HIV-1-Infected Individuals
    Knudsen, Andreas
    Benfield, Thomas
    Kofoed, Kristian
    SEXUALLY TRANSMITTED DISEASES, 2009, 36 (05) : 300 - 304
  • [37] The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
    Koks, CHW
    Crommentuyn, KML
    Hoetelmans, RMW
    Burger, DM
    Koopmans, PP
    Mathôt, RAA
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (06) : 631 - 635
  • [38] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 467 - 467
  • [39] IL-7 as a potential therapy for HIV-1-infected individuals
    Nunnari, G
    Pomerantz, RJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1421 - 1426
  • [40] Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
    Aouri, Manel
    Barcelo, Catalina
    Guidi, Monia
    Rotger, Margalida
    Cavassini, Matthias
    Hizrel, Cedric
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)